United States· US:75907-309_e5a52dad-e328-48f2-9182-4df46f5572ef
TRANEXAMIC ACID
A tranexamic acid product containing tranexamic acid, registered in United States by Dr. Reddy's Laboratories Inc.. The same ATC class is registered in 15 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Tranexamic acid is registered in 15 of 19 countries.
Countries holding a registration under ATC B02AA02 (tranexamic acid), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Tranexamic acid · ATC B02AA02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tranexamic acid costs, country by country.
Normalised to the WHO defined daily dose (2 g), the median price runs from $1.69 in Italy to $34.44 in Switzerland — a ×20 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tranexamic acid · price per daily dose (2 g)
USD · FX 28 Sept 2026
- CH Switzerland$34.44
- IT Italy$1.69
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TRANEXAMIC ACID
- Manufacturer
- Dr. Reddy's Laboratories Inc.
- Country
- United States (US)
- ATC code
- B02AA02
- ATC class
- Tranexamic acid
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1175907-309-30
- ndc11759073093030 TABLET in 1 BOTTLE (75907-309-30)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
45 interactions on record for tranexamic acid.
Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tranexamic acid · interactions on record
45 records
- 36 severe
- 8 moderate
- 1 minor
Most severe, free to view
- Faktor VIII-Inhibitor Bypass Aktivität - FEIBAB02BD03severe
- EstradiolD11AX34severe
- IUP aus Plastik mit GestagenG02BA03severe
- Levonorgestrel and ethinylestradiolG03AA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B02AA02
Tranexamic acid, as other registers publish it.
- SwitzerlandAcide tranexamique Stragen 1000 mg/10ml, solution injectableStragen Pharma SA
- SwitzerlandAcide tranexamique Stragen 1000 mg/10ml, solution injectableStragen Pharma SA
- SwitzerlandAcide tranexamique Stragen 500 mg/5ml, solution injectableStragen Pharma SA
- SwitzerlandAcide tranexamique Stragen 500 mg/5ml, solution injectableStragen Pharma SA
- ItalyACIDO TRANEXAMICO AUROBINDOEUGIA PHARMA (MALTA) LIMITED
- FinlandCaprilonEvolan Pharma AB
- FinlandCaprilonTakeda Oy
- United KingdomCyklo-f Heavy Period Relief 500mg tabletsThe Boots Company Plc
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d3fee115-11db-4c98-8693-d0c29afc89e6 GET /v1/drugs/d3fee115-11db-4c98-8693-d0c29afc89e6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "650",
"substance": "TRANEXAMIC ACID",
"productndc": "75907-309",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA218729",
"marketing_category": "ANDA"
}See everything about tranexamic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.